Form 4: Chimerix CFO Michelle LaSpaluto Reports Stock and Option Transactions

Chimerix's Chief Financial Officer, Michelle LaSpaluto, acquired shares and stock options, and also reported existing holdings, as part of a recent filing.

Summary

• Michelle LaSpaluto, the Chief Financial Officer of Chimerix, Inc., reported several transactions involving the company's stock.
• On January 7, 2025, she acquired 41,667 shares of common stock through restricted stock units (RSUs) at a price of $0.
• These RSUs vest over four years, with 10,416 shares vesting after one year, and 10,417 shares vesting annually for the following three years.
• She also acquired 250,000 stock options with an exercise price of $3.66, which vest over 40 months.
• The filing also includes existing holdings of 176,252 shares, which includes shares acquired through the Employee Stock Purchase Plan (ESPP) on March 8, 2024 (15,560 shares) and September 10, 2024 (8,026 shares).

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and insider transactions, which are generally viewed neutrally to slightly positive as it shows management's alignment with the company's success.

Positives

• The acquisition of shares and options by the CFO could be seen as a positive sign of her confidence in the company's future.
• The vesting schedule of the RSUs and stock options aligns with long-term value creation for the company.

Risks

• There are no specific risks mentioned in this document, but the value of the stock and options are subject to market fluctuations.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings and transactions of key executives.

Comparison to Industry Standards

• The vesting schedules for the RSUs and stock options are typical for executive compensation packages in the biotechnology industry.
• Many companies use a combination of stock options and restricted stock units to incentivize and retain key personnel.
• The ESPP participation is also a common practice to allow employees to purchase company stock at a discount.

Stakeholder Impact

• The transactions reported in this filing provide transparency to shareholders regarding executive compensation.
• The vesting schedules of the RSUs and stock options align the CFO's interests with the long-term performance of the company, which is beneficial for shareholders.

Key Dates

Keywords

Chimerix, Michelle LaSpaluto, stock options, restricted stock units, RSU, ESPP, insider trading, Form 4, executive compensation